Empowered Funds’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Buy
+59,978
New +$294K ﹤0.01% 2163

Other funds holding PRLD

Empowered Funds's PRLD Position: Q3 2026 in Review

Empowered Funds opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 59,978 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #2163 among its holdings.

59 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.

  • Empowered Funds held 59,978 shares of Prelude Therapeutics worth $235K as of Q3 2026.
  • Prelude Therapeutics was a new Empowered Funds position in Q3 2026.
  • Prelude Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2163 holding.
  • 59 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.